Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:405-413
doi: 10.1161/CIRCULATIONAHA.105.548727
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Babu-Narayan, S. V.
Right arrow Articles by Gatzoulis, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Babu-Narayan, S. V.
Right arrow Articles by Gatzoulis, M. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Diseases
*MRI Scans
Related Collections
Right arrow CT and MRI
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2006;113:405-413.)
© 2006 American Heart Association, Inc.


Imaging

Ventricular Fibrosis Suggested by Cardiovascular Magnetic Resonance in Adults With Repaired Tetralogy of Fallot and Its Relationship to Adverse Markers of Clinical Outcome

Sonya V. Babu-Narayan, BSc, MRCP; Philip J. Kilner, MD, PhD; Wei Li, MD, PhD; James C. Moon, MRCP; Omer Goktekin, MD; Periklis A. Davlouros, MD; Mohammed Khan, MPH; Siew Yen Ho, PhD, FRCPath; Dudley J. Pennell, MD, FRCP; Michael A. Gatzoulis, MD, PhD

From the Adult Congenital Heart Unit (S.V.B.-N., W.L., O.G., P.A.D., M.A.G.) and the Cardiovascular Magnetic Resonance Unit (S.V.B.-N., P.J.K., J.C.M., D.J.P.), Royal Brompton Hospital, London, United Kingdom; and the National Heart and Lung Institute (S.V.B.-N., P.J.K., W.L., M.K., S.Y.H., D.J.P., M.A.G.), Imperial College, London, United Kingdom.

Correspondence to Dr Sonya V. Babu-Narayan, Adult Congenital Heart Unit, Royal Brompton Hospital, Sydney St, London SW3 6NP, United Kingdom. E-mail sonya{at}doctors.org.uk

Received March 11, 2005; revision received October 28, 2005; accepted November 21, 2005.

Background— Late morbidity and mortality remain problematic after repair of tetralogy of Fallot (TOF). We hypothesized that fibrosis detected by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) would be present in adults with repaired TOF and would be related to adverse markers of outcome.

Method and Results— LGE was scored in the right and left ventricles (RV and LV) of 92 adult patients who had undergone TOF repair. RV LGE was seen in all patients at surgical sites located in the outflow tract (99%) or the site of ventricular septal defect patching (98%) and in the inferior RV insertion point (79%) and trabeculated myocardium (24%). LV LGE (53%) was located at the apex consistent with apical vent insertion (49%), in the inferior or lateral wall consistent with infarction (5%), or in other areas (8%). Patients with supramedian RV LGE score were older (38 versus 27 years, P<0.001) and more symptomatic (38% versus 8% in New York Heart Association class II or greater, P=0.001), had increased levels of atrial natriuretic peptide (7.3 versus 4.9 pmol/L, P=0.041), and had a trend to higher brain natriuretic peptide (12.3 versus 7.2 pmol/L, P=0.086), exercise intolerance (maximum VO2 24 versus 28 mL · min–1 · kg–1, P=0.021), RV dysfunction (RV end-systolic volume 61 versus 55 mL/m2, P=0.018; RV ejection fraction 50% versus 56%, P=0.007), and clinical arrhythmia (26% versus 10%, P=0.039). Non–apical vent LV LGE also correlated with markers of adverse outcome. In a multivariate model, RV LGE remained a predictor of arrhythmia.

Conclusions— RV and LV LGE were common after TOF repair and were related to adverse clinical markers, including ventricular dysfunction, exercise intolerance, and neurohormonal activation. Furthermore, RV LGE was significantly associated with clinical arrhythmia.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
CirculationHome page
A. Frigiola, V. Tsang, C. Bull, L. Coats, S. Khambadkone, G. Derrick, B. Mist, F. Walker, C. van Doorn, P. Bonhoeffer, et al.
Biventricular Response After Pulmonary Valve Replacement for Right Ventricular Outflow Tract Dysfunction: Is Age a Predictor of Outcome?
Circulation, September 30, 2008; 118(14_suppl_1): S182 - S190.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Bordachar, X. Iriart, J. Chabaneix, F. Sacher, S. Lafitte, P. Jais, M. Haissaguerre, J. Clementy, P. Dos Santos, and J.-B. Thambo
Presence of ventricular dyssynchrony and haemodynamic impact of right ventricular pacing in adults with repaired Tetralogy of Fallot and right bundle branch block
Europace, July 4, 2008; (2008) eun178v1.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
K. K. Witte, C. B. Pepper, J. C. Cowan, J. D. Thomson, K. M. English, and M. E. Blackburn
Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot
Europace, April 28, 2008; (2008) eun108v1.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A. Crean
Cardiovascular MR and CT in congenital heart disease
Heart, December 1, 2007; 93(12): 1637 - 1647.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
G.-P. Diller, K. Dimopoulos, H. Kafka, S. Y. Ho, and M. A. Gatzoulis
Model of chronic adaptation: right ventricular function in Eisenmenger syndrome
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H54 - H60.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y.-Y. Lam, M. G. Kaya, O. Goktekin, M. A. Gatzoulis, W. Li, and M. Y. Henein
Restrictive Right Ventricular Physiology: Its Presence and Symptomatic Contribution in Patients With Pulmonary Valvular Stenosis
J. Am. Coll. Cardiol., October 9, 2007; 50(15): 1491 - 1497.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Uebing, D. G. Gibson, S. V. Babu-Narayan, G. P. Diller, K. Dimopoulos, O. Goktekin, M. S. Spence, K. Andersen, M. Y. Henein, M. A. Gatzoulis, et al.
Right Ventricular Mechanics and QRS Duration in Patients With Repaired Tetralogy of Fallot: Implications of Infundibular Disease
Circulation, October 2, 2007; 116(14): 1532 - 1539.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
I. R. Henkens, A. van Straten, M. J. Schalij, M. G. Hazekamp, A. de Roos, E. E. van der Wall, and H. W. Vliegen
Predicting Outcome of Pulmonary Valve Replacement in Adult Tetralogy of Fallot Patients
Ann. Thorac. Surg., March 1, 2007; 83(3): 907 - 911.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. A. Harris, T. R. Johnson, P. M. Weinberg, and M. A. Fogel
Delayed-enhancement cardiovascular magnetic resonance identifies fibrous tissue in children after surgery for congenital heart disease
J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 676 - 681.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
G. P. McCann, C. T. Gan, A. M. Beek, H. W. M. Niessen, A. V. Noordegraaf, and A. C. van Rossum
Extent of MRI Delayed Enhancement of Myocardial Mass Is Related to Right Ventricular Dysfunction in Pulmonary Artery Hypertension
Am. J. Roentgenol., February 1, 2007; 188(2): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Ooi, N. Moorjani, G. Baliulis, B. R. Keeton, A. P. Salmon, J. L. Monro, and M. P. Haw
Medium term outcome for infant repair in tetralogy of Fallot: indicators for timing of surgery
Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 917 - 922.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
E. A Shinebourne, S. V Babu-Narayan, and J. S Carvalho
Tetralogy of Fallot: from fetus to adult.
Heart, September 1, 2006; 92(9): 1353 - 1359.
[Full Text] [PDF]